IRIS
ALGERI, MATTIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.887
SA - Sud America 1.443
NA - Nord America 496
EU - Europa 332
AF - Africa 80
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.239
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 1.132
VN - Vietnam 649
SG - Singapore 616
US - Stati Uniti d'America 444
CN - Cina 258
IN - India 170
AR - Argentina 123
IT - Italia 97
EC - Ecuador 89
ID - Indonesia 59
DE - Germania 55
BD - Bangladesh 36
CO - Colombia 35
GB - Regno Unito 28
MX - Messico 27
RU - Federazione Russa 25
UA - Ucraina 25
ZA - Sudafrica 25
PY - Paraguay 23
NL - Olanda 21
AT - Austria 19
FI - Finlandia 19
MA - Marocco 18
CL - Cile 13
HK - Hong Kong 13
PK - Pakistan 13
PE - Perù 12
CA - Canada 11
IQ - Iraq 11
VE - Venezuela 11
KE - Kenya 10
TN - Tunisia 10
PL - Polonia 9
SA - Arabia Saudita 8
EG - Egitto 7
UZ - Uzbekistan 7
ES - Italia 6
FR - Francia 6
IL - Israele 6
TR - Turchia 5
UY - Uruguay 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
KZ - Kazakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
IR - Iran 3
JO - Giordania 3
NP - Nepal 3
QA - Qatar 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
CR - Costa Rica 2
GA - Gabon 2
HN - Honduras 2
KG - Kirghizistan 2
LB - Libano 2
NG - Nigeria 2
PA - Panama 2
RS - Serbia 2
SE - Svezia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
BW - Botswana 1
CY - Cipro 1
GE - Georgia 1
JM - Giamaica 1
JP - Giappone 1
LK - Sri Lanka 1
MY - Malesia 1
OM - Oman 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.239
Salva come PNG Salva come JPEG
Città #
Ho Chi Minh City 241
Singapore 218
Santa Clara 155
Bengaluru 149
Hefei 149
Hanoi 143
Dallas 101
São Paulo 84
Beijing 54
Ashburn 42
Rio de Janeiro 36
Guayaquil 34
Munich 34
Haiphong 32
Da Nang 28
Rome 23
Quito 20
Thái Bình 19
Belo Horizonte 18
Campinas 18
Biên Hòa 17
Brasília 17
Porto Alegre 17
Curitiba 16
Ribeirão Preto 16
Buenos Aires 14
Hải Dương 14
Hong Kong 13
Johannesburg 13
Guarulhos 12
Helsinki 12
Nuremberg 12
Thái Nguyên 12
Fortaleza 11
London 11
Milan 11
Salvador 11
Boardman 10
Goiânia 10
Asunción 9
Bogotá 9
Bắc Ninh 9
Nairobi 9
New York 9
Santo André 9
Can Tho 8
Cape Town 8
Jakarta 8
Lấp Vò 8
Palermo 8
Quảng Ngãi 8
Sorocaba 8
Uberlândia 8
Amsterdam 7
Duque de Caxias 7
Juiz de Fora 7
Lima 7
Ourinhos 7
Recife 7
São Bernardo do Campo 7
Tashkent 7
Tunis 7
Belém 6
Boydton 6
Corrientes 6
Dhaka 6
Ha Long 6
Joinville 6
Maceió 6
Medellín 6
Ninh Bình 6
Osasco 6
Turku 6
Vallefiorita 6
Warsaw 6
Araraquara 5
Baghdad 5
Bauru 5
Bento Gonçalves 5
Bình Dương 5
Ciudad del Este 5
Macapá 5
Mauá 5
Mexico City 5
Nha Trang 5
Nova Iguaçu 5
Santa Maria 5
Suzano 5
São Luís 5
São Vicente 5
Araucária 4
Birigui 4
Brooklyn 4
Cabo Frio 4
Camaçari 4
Campos dos Goytacazes 4
Canoas 4
Capivari 4
Formosa 4
Hortolândia 4
Totale 2.221
Salva come PNG Salva come JPEG
Nome #
Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL 59
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma 57
In vitro Cytotoxic Effect of Trabectedin on JMML AND CMML Cell Populations 53
Availability of HLA-allele-matched unrelated donors and registry size: Estimation from haplotype frequency in the Italian population 47
Autologous gene therapy for hemoglobinopathies: From bench to patient's bedside 45
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiency 43
Achievement of operational tolerance in a pediatric liver transplant recipient following successful hematopoietic stem cell transplantation from a different donor 43
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation 41
T-Cell Depleted HLA-Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (haplo-HSCT) Followed By Donor Lymphocyte Infusion with T Cells Transduced with the Inducible Caspase 9 (iC9) Suicide Gene in Children with Hematological Malignancies 41
Outcome of children with acute leukemia given allogeneic HSCT either from an unrelated donor (UD-HSCT) or from an HLA-partially matched relative after αß-T cell/B-cell depletion (αßhaplo-HSCT) 40
IMPACT OF POST-TRANSPLANT INFUSION OF DONOR T CELLS GENETICALLY MODIFIED WITH INDUCIBLE CASPASE 9 SUICIDE GENE (BPX-501 CELLS) ON CHILDREN WITH LEUKEMIA GIVEN ALPHA-BETA T-CELL DEPLETED HAPLO-HSCT 40
CAR.CD123-NK Cells Have an Equally Effective but Safer Off-Tumor/on-Target Profile As Compared to CARCD123-T Cells for the Treatment of Acute Myeloid Leukaemia 40
Betibeglogene autotemcel gene therapy for non–β0/β0 genotype β-thalassemia 40
Management of pediatric patients with anti-HLA antibodies undergoing T-cell depleted haploidentical hematopoietic stem cell transplantation 39
Autologous CD19‐Targeting CAR T Cells in a Patient With Refractory Juvenile Dermatomyositis 38
GENERATION OF CYTOTOXIC T LYMPHOCYTES BY DONOR-SPECIFIC CSE PEPTO WT1 AND WITH CYTOTOXIC ACTIVITY TOWARDS LEUKEMIC BLASTS OF THE PATIENT FOR ADOPTIVE IMMUNOTHERAPY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS. 38
Resistance to neoplastic transformation of ex-vivo expanded human mesenchymal stromal cells after exposure to supramaximal physical and chemical stress 38
Comprehensive characterization of bone-marrow mesenchymal stromal cells isolated from patients affected by primary immunodeficiency 38
TCRαβ +/CD19 + - Depleted HLA-Haploidentical Hematopoietic Stem Cell Traansplantation in Pediatric Patient with Fanconi Anemia 38
TCRab/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders 37
A phase I study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome 37
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantation 37
Cord blood transplantation for acute leukemia 37
Circulating Extracellular Vesicles Impair Mesenchymal Stromal Cell Differentiation Favoring Adipogenic Rather than Osteogenic Differentiation in Adolescents with Obesity 37
Decellularized esophageal tubular scaffold microperforated by quantum molecular resonance technology and seeded with mesenchymal stromal cells for tissue engineering esophageal regeneration 37
Alpha/beta T-cell depleted Haploidentical HSCT followed by infusion of donor lymphocytes transduced with inducible caspase9 gene is safe and effective for patients with erythroid disorders 36
ABATACEPT REDUCES ACUTE GVHD INCIDENCE IN PEDIATRIC PATIENTS TRANSPLANTED FROM HLA-MISMATCHED UNRELATED DONORS 36
Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease and Graft Failure in Patients with Non-Malignant Disorders: Results of a Multicentre, Randomized, Open-Label Study 36
Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia 36
Human leukocyte antigen evolutionary divergence influences outcomes of paediatric patients and young adults affected by malignant disorders given allogeneic haematopoietic stem cell transplantation from unrelated donors 36
Use of emapalumab in the peri-transplant period to prevent graft failure in patients at risk 36
T Cell-Depleted and T Cell-Replete HLA-Haploidentical Stem Cell Transplantation for Non-malignant Disorders 36
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (Tbdepl-Haplohsct) in Children with Non-Malignant Disorders 36
FINAL RESULTS OF THE PHASE 3 STUDIES NORTHSTAR-2 AND NORTHSTAR-3 IN PATIENTS WITH TRANSFUSION-DEPENDENT β-THALASSEMIA (TDT): SUBGROUP ANALYSIS OF ITALIAN PATIENTS TREATED WITH BETIBEGLOGENE AUTOTEMCEL (BETI-CEL), LENTIGLOBIN FOR THALASSEMIA 35
T-cell depleted HLA-haploidentical HSCT in a child with neuromyelitis optica 35
A new BSA-based Threshold Predicts Optimal PBSC Collection in T-cell Depleted HLA-haploidentical Stem Cell Transplantation 35
Natural history of Ras‐associated autoimmune leukoproliferative disorder: A 20-year follow-up of a NRAS-mutated patient excluding a malignant progression 35
Alpha/Beta T-Cell and B-Cell Depletion HLA-Haploidentical Hematopoietic Stem Cell Transplantation Is an Effective Treatment for Children/Young Adults with Acute Leukemia 35
Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia 35
BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) FACILITATES HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT IN CHILDREN WITH BOTH HEMATOLOGICAL MALIGNANCIES AND NON-MALIGNANT CONDITIONS 35
Unmanipulated donor lymphocyte infusion (dli) after ab-t and b-cell depleted haploidentical stem cell transplantation 35
Gata2 related conditions and predisposition to pediatric myelodysplastic syndromes 35
P1361: TREATMENT OF SEVERE STEROID-REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE-BLIND MULTI-CENTER HOVON-113 TRIAL 35
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells isolated from pediatric patients affected by acute myeloid leukemia 35
Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) in Children with Myelodysplastic Syndromes 34
Outcome of children with ALL in second complete remission transplanted from an unrelated donor: a retrospective analysis 34
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia 34
Outcome of Children with Acute Leukemia Given Allogeneic HSCT Either from an Unrelated Donor or from an HLA-Partially Matched Relative after αβ-T Cell/B-Cell Depletion: A Multicenter, Retrospective, Comparative Analysis of the AIEOP Network 34
Donor T Cells Genetically Modified with a Novel Suicide Gene (inducible Caspase 9, iC9) Expand and Persist over Time after Post-Allograft Infusion in Patients Given αβ T-Cell and B-Cell Depleted HLA-Haploidentical Allogeneic Stem Cell Transplantation (αβ haplo-HSCT) Contributing to Accelerate Immune Recovery 34
Ruxolitinib as the first post-steroid treatment for acute and chronic graft-versus-host disease 34
Use of Ruxolitinib in Pediatric Patients with Steroid-Refractory Graft-versus-host Disease (GVHD) 34
Treosulfan Exposure in Pediatric Hematopoietic Stem Cell Transplantation is Associated with Early Toxicity but not with event-free Survival 33
Improved T- and B-Cell Neogenesis in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Combined with the Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (Rivo-cel) 33
Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy 33
T- and B-Cell Neogenesis Recovers Efficiently in Children with Acute Leukemia Given an Alpha-Beta T-Cell Depleted Haplo-HSCT Followed By Infusion of Donor T-Cells Genetically Modified with Inducible Caspase 9 Suicide Gene (BPX-501 cells) 33
TCRαβ/CD19 cell–depleted HLA-haploidentical transplantation to treat pediatric acute leukemia: updated final analysis 32
Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL? 32
THE USE OF BPX-501 DONOR T CELL INFUSION (WITH INDUCIBLE CASPASE 9 SUICIDE GENE) TOGETHER WITH HLA-HAPLOIDENTICAL STEM CELL TRANSPLANT TO TREAT CHILDREN WITH HEMOGLOBINOPATHIES AND ERYTHROID DISORDERS 32
Decolonization of multi-drug resistant bacteria by fecal microbiota transplantation in five pediatric patients before allogeneic hematopoietic stem cell transplantation: Gut microbiota profiling, infectious and clinical outcomes 32
Mesenchymal stromal cells and chronic inflammatory bowel disease 32
Genome editing for sickle cell disease: still time to correct? 32
Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy 31
NIRMATRELVIR/RITONAVIR AND TIXAGEVIMAB/CILGAVIMAB AS SARS-COV-2 TREATMENT IN PEDIATRIC AND YOUNG ADULT PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) OR CD19-DIRECTED CAR T-CELL TREATMENT 31
Administration of BPX-501 Cells Following Αβ T and B-Cell-Depleted HLA-Haploidentical HSCT (haplo-HSCT) in Children with Malignant or Non-Malignant Disorders 31
Academic, Phase I/II Trial on T Cells Expressing a Second Generation, CD19-Specific Chimeric Antigen Receptor (CAR) and Inducible Caspase 9 Safety Switch for the Treatment of B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) and B-Cell Non-Hodgkin Lymphoma (B-NHL) in Children 31
Novel Therapeutic Approaches to Familial HLH (Emapalumab in FHL) 31
Lymphocyte Collection for Generation of CAR T-cells in Pediatric Patients: A Single Center Experience 31
Outcome of Children with Wiskott-Aldrich Syndrome (WAS) Given TCR Alpha-Beta/CD19 Depleted Hematopoietic Stem Cell Transplantation (HSCT) from an HLA-Haploidentical Relative 31
Pre-Transplant Levels of Multiparametric Flow-Cytometry Measurable Residual Disease (MFC-MRD) Predict Outcomes in Children with Acute Myeloid Leukemia Given Allogeneic Hematopoietic Stem Cell Transplantation 31
Mucosal-Associated Invariant T (MAIT) Cells Are Functionally Impaired in Pediatric Patients Following HCT and Their Recovery Is Associated with the Onset of GvHD 31
CD19 REDIRECTED CAR NK CELLS ARE EQUALLY EFFECTIVE BUT LESS TOXIC THAN CAR T CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA 31
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders 31
Results of a Multicentre, Randomized, Controlled Open-Label Study on the Use of Anti-T-Lymphocyte Globulin (ATLG) and Rituximab for Immunomodulation of Graft-Versus-Host Disease (GvHD) and Graft Failure (GF) in Patients with Non-Malignant Disorders 31
Current and future role of bispecific T-cell engagers in pediatric acute lymphoblastic leukemia 31
Long-Term Outcome of Children with Acute Leukemia (AL) Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 31
A new promising, third-generation (3RD) CAR-CD30 T cells therapy for CD30+lymphoma patients 31
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in Children 30
Outcomes of children with primary immunodeficiencies receiving alpha/beta T-cell depleted HLA-haplo-HSCT followed by infusion of lymphocytes transduced with the inducible caspase 9 (iC9) suicide gene 30
Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome 30
LONG-TERM DATA ON IMMUNE MONITORING OF CHILDREN GIVEN TCRαβ/CD19 CELL DEPLETED HLA-HAPLOIDENTICAL STEM TRANSPLANTATION (HAPLO-HSCT) 30
Brentuximab in Children, Adolescent and Young Adults with Relapsed/Refractory Anaplastic Large Cell Lymphoma 30
Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Cerebral Adrenoleukodystrophy: Outcomes by Donor Cell Source And Match, Conditioning Regimen, And Stage of Cerebral Disease 30
Busulfan–fludarabine- or treosulfan–fludarabine-based myeloablative conditioning for children with thalassemia major 30
Allogeneic CD19-CAR T cells: a promising treatment for pediatric patients with highly refractory BCP-ALL relapsing after allogeneic hematopoietic stem cells transplant (allo-HSCT) 29
Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia 29
Monitoring of T-cell responses to viral-coded antigens in pediatric patients receiving TCRαβ-depleted haplo-HSCT followed by BPX-501 cell administration 29
NK Cells and PMN-MDSCs in the Graft From G-CSF Mobilized Haploidentical Donors Display Distinct Gene Expression Profiles From Those of the Non-Mobilized Counterpart 28
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties 28
SUCCESS OF PERSONALIZED RUXOLITINIB TREATMENT BASED ON THERAPEUTIC DRUG MONITORING IN PEDIATRIC PATIENTS WITH PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ALLOWING BRIDGING TO HSCT 28
Outcome of Children with Different Non-Malignant Disorders Given Alphabeta T and B-Cell Depleted HLA-Haploidentical Hematopoietic Stem Cell Transplantation (TBdepl-haploHSCT) 28
Dissecting the mechanisms of bone loss in Gorham-Stout disease 28
Unrelated donor vs HLA-haploidentical a/b T-cell– and B-cell–depleted HSCT in children with acute leukemia 28
Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation 28
Comprehensive characterization of mesenchymal stromal cells from patients with Fanconi anaemia 27
Impact of Treosulfan Exposure on Early and Long-Term Clinical Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Prospective Multicenter Study 27
Matched unrelated donor transplantation versus haploidentical transplantation with post-transplant cyclophosphamide in children with acute myeloid leukemia: a PDWP-EBMT study 27
Lentiglobin Gene Therapy Treatment of Two Patients with Transfusion-dependent ß-thalassemia 27
Implementation of a quality system for running a cell and gene therapy clinical trial within a JACIE-accredited transplant program 27
Outcomes of HLA-mismatched HSCT with TCRαβ/CD19 depletion or post-HSCT cyclophosphamide for inborn errors of immunity 26
Successful muscle regeneration by a homologous microperforated scaffold seeded with autologous mesenchymal stromal cells in a porcine esophageal substitution model 26
Totale 3.420
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202412 0 0 0 0 0 0 0 0 0 0 12 0
2024/20251.185 4 0 3 402 66 165 60 29 95 70 59 232
2025/20263.241 75 395 813 1.601 319 38 0 0 0 0 0 0
Totale 4.438